214 related articles for article (PubMed ID: 34080517)
1. Pharmacotherapy for recurrent respiratory papillomatosis (RRP): a treatment update.
Donne AJ; Kinshuck A
Expert Opin Pharmacother; 2021 Oct; 22(14):1901-1908. PubMed ID: 34080517
[No Abstract] [Full Text] [Related]
2. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
3. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
[TBL] [Abstract][Full Text] [Related]
4. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
[TBL] [Abstract][Full Text] [Related]
5. [Recurrent respiratory papillomatosis: indication for HPV vaccination?].
Pawlita M; Gissmann L
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S100-2. PubMed ID: 19353471
[TBL] [Abstract][Full Text] [Related]
6. Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature.
Katsuta T; Miyaji Y; Offit PA; Feemster KA
J Pediatric Infect Dis Soc; 2017 Nov; 6(4):380-385. PubMed ID: 28992265
[TBL] [Abstract][Full Text] [Related]
7. Biologics for the Treatment of Recurrent Respiratory Papillomatosis.
Allen CT
Otolaryngol Clin North Am; 2021 Aug; 54(4):769-777. PubMed ID: 34099306
[TBL] [Abstract][Full Text] [Related]
8. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Ablanedo-Terrazas Y; Estrada-Camacho O; Alvarado-de la Barrera C; Ramírez-García A; Tona-Acedo G; Bross-Soriano D; Schimelmitz-Idi J
Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(2):82-88. PubMed ID: 35397828
[TBL] [Abstract][Full Text] [Related]
10. [Perspectives on recurrent respiratory papillomatosis and human papillomavirus].
Trolle S; Lynggaard CD; Gregersen KG; Baandrup L; Grønhøj C; Buchwald CV
Ugeskr Laeger; 2019 Oct; 181(41):. PubMed ID: 31610833
[TBL] [Abstract][Full Text] [Related]
11. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases.
Bedoya A; Glisinski K; Clarke J; Lind RN; Buckley CE; Shofer S
Am J Case Rep; 2017 Jul; 18():842-846. PubMed ID: 28757601
[TBL] [Abstract][Full Text] [Related]
12. [Research progress in the adjunct therapy of recurrent respiratory papillomatosis].
Shen M; Xiao Y; Ma L; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Dec; 34(12):1145-1148. PubMed ID: 33254355
[No Abstract] [Full Text] [Related]
13. Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
Chirilă M; Bolboacă SD
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1135-42. PubMed ID: 24121781
[TBL] [Abstract][Full Text] [Related]
14. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
15. Update on Recurrent Respiratory Papillomatosis.
Derkay CS; Bluher AE
Otolaryngol Clin North Am; 2019 Aug; 52(4):669-679. PubMed ID: 31078306
[TBL] [Abstract][Full Text] [Related]
16. Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.
Smahelova J; Hamsikova E; Ludvikova V; Vydrova J; Traboulsi J; Vencalek O; Lukeš P; Tachezy R
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):654-661. PubMed ID: 35653138
[TBL] [Abstract][Full Text] [Related]
17. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
18. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of the use of human papillomavirus vaccine as adjuvant therapy for juvenile-onset recurrent respiratory papillomatosis.
Park I; Carbone S; Preciado D
Int J Pediatr Otorhinolaryngol; 2022 Nov; 162():111314. PubMed ID: 36116179
[TBL] [Abstract][Full Text] [Related]
20. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
Bertino G; Pedretti F; Mauramati S; Filauro M; Vallin A; Mora F; Crosetti E; Succo G; Peretti G; Benazzo M
Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S111-S122. PubMed ID: 37698108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
